Equity (Tables)

6 Months Ended

Jun. 30, 2023

Equity [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights

During the three and six months ended June 30, 2023, there were no warrants issued, exercised, or canceled. See Note 10 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022 for further discussion of the terms related to the Company’s warrants.

	Number of Warrants
	Equity classified		Liability classified		Total		Weighted average exercise price
Outstanding at June 30, 2023		2,236,326		28,991,953		31,228,279	$	1.53

Schedule of Authorized Shares of Common Stock for Future Issuance

The Company has authorized shares of common stock for future issuance as of June 30, 2023 as follows:

Exercise of warrants	31,228,279
Shares available for future stock incentive awards	8,073,729
RSUs reserved for issuance	125
Unvested restricted stock units	2,411,792
Outstanding common stock options	20,114,139
Accrued Ginkgo Bioworks Holdings, Inc. milestone award	1,339,285
Total	63,167,349